Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells - PubMed (original) (raw)
doi: 10.1530/JOE-12-0142. Epub 2012 May 4.
Ilaria Cellai, Raffaella Santi, Letizia Lombardelli, Annamaria Morelli, Paolo Comeglio, Sandra Filippi, Federica Logiodice, Marco Carini, Gabriella Nesi, Mauro Gacci, Marie-Pierre Piccinni, Luciano Adorini, Mario Maggi
Affiliations
- PMID: 22562653
- DOI: 10.1530/JOE-12-0142
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells
Linda Vignozzi et al. J Endocrinol. 2012 Jul.
Erratum in
- J Endocrinol. 2012 Aug;214(2):239
Abstract
Progression of benign prostatic hyperplasia (BPH) involves chronic inflammation and immune dysregulation. Preclinical studies have demonstrated that prostate inflammation and tissue remodeling are exacerbated by hypogonadism and prevented by testosterone supplementation. We now investigated whether, in humans, hypogonadism was associated with more severe BPH inflammation and the in vitro effect of the selective androgen receptor agonist dihydrotestosterone (DHT) on cultures of stromal cells derived from BPH patients (hBPH). Histological analysis of inflammatory infiltrates in prostatectomy specimens from a cohort of BPH patients and correlation with serum testosterone level was performed. Even after adjusting for confounding factors, hypogonadism was associated with a fivefold increased risk of intraprostatic inflammation, which was also more severe than that observed in eugonadal BPH patients. Triggering hBPH cells by inflammatory stimuli (tumor necrosis factor α, lipopolysaccharide, or CD4(+)T cells) induced abundant secretion of inflammatory/growth factors (interleukin 6 (IL6), IL8, and basic fibroblast growth factor (bFGF)). Co-culture of CD4(+)T cells with hBPH cells induced secretion of Th1 inducer (IL12), Th1-recruiting chemokine (interferon γ inducible protein 10, IP10), and Th2 (IL9)- and Th17 (IL17)-specific cytokines. Pretreatment with DHT inhibited NF-κB activation and suppressed secretion of several inflammatory/growth factors, with the most pronounced effects on IL8, IL6, and bFGF. Reduced inflammatory cytokine production by T-cells, an increase in IL10, and a significant reduction of T cells proliferation suggested that DHT exerted a broad anti inflammatory effect on testosterone cells [corrected]. In conclusion, our data demonstrate that DHT exerts an immune regulatory role on human prostatic stromal cells, inhibiting their potential to actively induce and/or sustain autoimmune and inflammatory responses.
Similar articles
- Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation.
Vignozzi L, Gacci M, Cellai I, Santi R, Corona G, Morelli A, Rastrelli G, Comeglio P, Sebastanelli A, Maneschi E, Nesi G, De Nunzio C, Tubaro A, Mannucci E, Carini M, Maggi M. Vignozzi L, et al. Prostate. 2013 Jun;73(8):789-800. doi: 10.1002/pros.22623. Epub 2012 Nov 28. Prostate. 2013. PMID: 23620238 - The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G, Fibbi B, Amuchastegui S, Corsiero E, Laverny G, Silvestrini E, Chavalmane A, Morelli A, Sarchielli E, Vannelli GB, Gacci M, Colli E, Maggi M, Adorini L. Penna G, et al. Prostate. 2009 Apr 1;69(5):480-93. doi: 10.1002/pros.20896. Prostate. 2009. PMID: 19107880 - Androgen and prostatic stroma.
Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G. Niu YJ, et al. Asian J Androl. 2003 Mar;5(1):19-26. Asian J Androl. 2003. PMID: 12646998 - Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
Fibbi B, Penna G, Morelli A, Adorini L, Maggi M. Fibbi B, et al. Int J Androl. 2010 Jun 1;33(3):475-88. doi: 10.1111/j.1365-2605.2009.00972.x. Epub 2009 Jun 8. Int J Androl. 2010. PMID: 19508330 Review. - Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
Kramer G, Mitteregger D, Marberger M. Kramer G, et al. Eur Urol. 2007 May;51(5):1202-16. doi: 10.1016/j.eururo.2006.12.011. Epub 2006 Dec 11. Eur Urol. 2007. PMID: 17182170 Review.
Cited by
- Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice.
Dowman JK, Hopkins LJ, Reynolds GM, Armstrong MJ, Nasiri M, Nikolaou N, van Houten EL, Visser JA, Morgan SA, Lavery GG, Oprescu A, Hübscher SG, Newsome PN, Tomlinson JW. Dowman JK, et al. Endocrinology. 2013 Dec;154(12):4536-47. doi: 10.1210/en.2013-1592. Epub 2013 Sep 30. Endocrinology. 2013. PMID: 24080367 Free PMC article. - Inflammatory Stimuli Trigger Increased Androgen Production and Shifts in Gene Expression in Theca-Interstitial Cells.
Fox CW, Zhang L, Sohni A, Doblado M, Wilkinson MF, Chang RJ, Duleba AJ. Fox CW, et al. Endocrinology. 2019 Dec 1;160(12):2946-2958. doi: 10.1210/en.2019-00588. Endocrinology. 2019. PMID: 31599939 Free PMC article. - Lessons learned about prostatic transformation from the age-related methylation of 5α-reductase type 2 gene.
Isaacs JT. Isaacs JT. Am J Pathol. 2015 Mar;185(3):614-6. doi: 10.1016/j.ajpath.2015.01.001. Epub 2015 Feb 17. Am J Pathol. 2015. PMID: 25700984 Free PMC article. - Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.
Tsilidis KK, Rohrmann S, McGlynn KA, Nyante SJ, Lopez DS, Bradwin G, Feinleib M, Joshu CE, Kanarek N, Nelson WG, Selvin E, Platz EA. Tsilidis KK, et al. Andrology. 2013 Nov;1(6):919-28. doi: 10.1111/j.2047-2927.2013.00129.x. Epub 2013 Sep 30. Andrology. 2013. PMID: 24124163 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials